Heart Matters



  Guest: Ana Barac, MD, PhD 


  
    The American College of Cardiology's 72nd Scientific Session &amp; Expo featured the latest advancements in all fields of cardiovascular medicine, including cardio-oncology. To learn more, Dr. Javed Butler sits down with Dr. Ana Barac from the MedStar Washington Hospital Center to take a look at clinical data from the STOP-CA trial.

Cardio-Oncology: Key Clinical Data from ACC.23


Updates from ACC 2023: Examining Transcatheter Repair Study Data


Guest: Ana Barac, MD, PhD 


  
    The American College of Cardiology's 72nd Scientific Session &amp; Expo featured the latest advancements in all fields of ca



  Host: Javed Butler, MD <br>

  Guest: Chiadi Ndumele, M.D., Ph.D., M.H.S. <br>


  
    <p>For the first time, the American Heart Association (AHA) has identified cardiovascular-kidney-metabolic (CKM) syndrome, which reflects a strong overlap between heart disease, kidney disease, and obesity. The major clinical consequence of CKM syndrome is multi-organ dysfunction with a particularly high incidence and burden of cardiovascular disease (CVD), and the result of this is premature morbidity and mortality. So as a result, recognizing CKM syndrome is the first step in earlier diagnosis and treatment. Dive into this episode with Dr. Javed Butler who’s joined by Dr. Chiadi Ndumele, Associate Professor of Medicine and the Director of Obesity and Cardiometabolic Research at Johns Hopkins University.</p>